Donà G, Giuliani P, Cremonesi P, Passaro A, Stella P, Tursi F, Mizrahi J
Italfarmaco Research Center, Italfarmaco S.p.A., Milan, Italy.
J Cardiovasc Pharmacol. 1995;26 Suppl 4:S59-66.
The vasorelaxant properties of ITF 296, a new mononitrate ester, were studied in endothelium-denuded rabbit aortic rings and were compared to nitroglycerin (NTG) and isosorbide dinitrate (ISDN). In norepinephrine-contracted arteries, ITF 296, NTG, and ISDN elicited maximal and concentration-dependent vasodilation with pD2 values of 7.07, 7.95, and 7.2, respectively. The concentration-relaxation curves of ITF 296 were shifted markedly to the right (p < 0.01) in the presence of 10 microM methylene blue (MB) and 3 microM oxyhemoglobin (HbO2), whereas a significant shift to the left (p < 0.01) was observed in the presence of 10 microM M&B-22948 (a specific cGMP phosphodiesterase inhibitor). When KCl (60 mM) was used as contracting agent, a weak relaxation was observed with ITF 296, suggesting the absence of activity on the voltage-dependent Ca2+ channels. A time-dependent increase in cGMP content and a positive correlation between cGMP and vasodilation were observed in norepinephrine-contracted arteries after exposure to a single submaximal concentration of ITF 296 (1 microM). Similar results were obtained with NTG and ISDN, although NTG was found to be more active than ITF 296 or ISDN. The presence of either MB or HbO2 almost completely abolished the increase in cGMP induced by ITF 296, whereas a further increase in cGMP was observed in the presence of isobutylmethylxanthine. No changes in cAMP levels were observed after exposure of the tissues to a concentration of ITF 296 that induced significant elevation in the cGMP content. In the presence of L-cysteine, ITF 296 stimulated semipurified rat lung guanylate cyclase at higher concentrations than those of NTG or ISDN, probably because of its lower rate of nitric oxide (NO) release. These results suggest that, in common with the reference compounds NTG and ISDN, ITF 296-induced vasorelaxation in rabbit aortic rings is mediated by an NO-cGMP mechanism.
研究了新型单硝酸酯ITF 296对去内皮兔主动脉环的血管舒张特性,并与硝酸甘油(NTG)和异山梨醇二硝酸酯(ISDN)进行了比较。在去甲肾上腺素收缩的动脉中,ITF 296、NTG和ISDN均引起最大且浓度依赖性的血管舒张,其pD2值分别为7.07、7.95和7.2。在存在10微摩尔亚甲蓝(MB)和3微摩尔氧合血红蛋白(HbO2)的情况下,ITF 296的浓度-舒张曲线明显右移(p < 0.01),而在存在10微摩尔M&B-22948(一种特异性cGMP磷酸二酯酶抑制剂)的情况下,观察到明显左移(p < 0.01)。当使用氯化钾(60毫摩尔)作为收缩剂时,ITF 296观察到微弱的舒张作用,表明其对电压依赖性Ca2+通道无活性。在去甲肾上腺素收缩的动脉中,暴露于单一亚最大浓度的ITF 296(1微摩尔)后,观察到cGMP含量随时间增加,且cGMP与血管舒张呈正相关。NTG和ISDN也得到了类似结果,尽管发现NTG比ITF 296或ISDN更具活性。MB或HbO2的存在几乎完全消除了ITF 296诱导的cGMP增加,而异丁基甲基黄嘌呤存在时观察到cGMP进一步增加。将组织暴露于诱导cGMP含量显著升高的ITF 296浓度后,未观察到cAMP水平的变化。在存在L-半胱氨酸的情况下,ITF 296比NTG或ISDN在更高浓度下刺激半纯化的大鼠肺鸟苷酸环化酶,这可能是因为其一氧化氮(NO)释放速率较低。这些结果表明,与参考化合物NTG和ISDN一样,ITF 296在兔主动脉环中诱导的血管舒张是由NO-cGMP机制介导的。